Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2013, Article ID 127270, 8 pages
http://dx.doi.org/10.1155/2013/127270
Review Article

Novel Antiplatelet Agent Use for Acute Coronary Syndrome in the Emergency Department: A Review

Department of Family Medicine, University of Calgary, 1632 14 Avenue NW, Calgary, AB, Canada T2N 1M7

Received 11 October 2012; Revised 24 December 2012; Accepted 18 January 2013

Academic Editor: Ping-Yen Liu

Copyright © 2013 M. Curial et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. R. Arora and F. Rai, “Antiplatelet intervention in acute coronary syndrome,” American Journal of Therapeutics, vol. 16, no. 5, pp. e29–e40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. A. A. Fox, S. R. Mehta, R. Peters et al., “Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non- ST-elevation acute coronary syndrome: the clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial,” Circulation, vol. 110, no. 10, pp. 1202–1208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Gurbel and U. S. Tantry, “Clopidogrel resistance?” Thrombosis Research, vol. 120, no. 3, pp. 311–321, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. M. Vila, M. U. Zafar, and J. J. Badimon, “Platelet reactivity and nonresponse to dual antiplatelet therapy: a review,” Platelets, vol. 20, no. 8, pp. 531–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. D. Wiviott, D. Trenk, A. L. Frelinger et al., “Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial,” Circulation, vol. 116, no. 25, pp. 2923–2932, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. A. Gurbel, K. P. Bliden, K. Butler et al., “Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: The RESPOND Study,” Circulation, vol. 121, no. 10, pp. 1188–1199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Valgimigli, M. Tebaldi, G. Campo et al., “Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugreladministration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO, (Facilitation through Aggrastat by dropping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dose) trial,” Journal of the American College of Cardiology, vol. 5, no. 3, pp. 268–277, 2012. View at Google Scholar
  8. “Clopidogrel,” in UpToDate, D. S. Basow, Ed., UpToDate, Waltham, Mass, USA, 2012.
  9. D. W. Marion, “Ticagrelor,” in UpToDate, D. S. Basow, Ed., UpToDate, Waltham, Mass, USA, 2012. View at Google Scholar
  10. D. W. Marion, “Prasugrel,” in UpToDate, D. S. Basow, Ed., UpToDate, Waltham, Mass, USA, 2012. View at Google Scholar
  11. S. D. Wiviott, E. Braunwald, C. H. McCabe et al., “Prasugrel versus clopidogrel in patients with acute coronary syndromes,” The New England Journal of Medicine, vol. 357, no. 20, pp. 2001–2015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. T. Roe, P. W. Armstrong, K. A. Fox et al., “Prasugrel versus clopidogrel for acute coronary syndromes without revascularization,” The New England Journal of Medicine, vol. 367, no. 14, pp. 1297–1309, 2012. View at Google Scholar
  13. E. M. Antman, M. Cohen, P. J. L. M. Bernink et al., “The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making,” Journal of the American Medical Association, vol. 284, no. 7, pp. 835–842, 2000. View at Google Scholar · View at Scopus
  14. S. D. Wiviott, E. M. Antman, C. M. Gibson et al., “Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38),” American Heart Journal, vol. 152, no. 4, pp. 627–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. B. Song, J. Y. Hahn, H. C. Gwon et al., “A high loading dose of clopidogrel reduces myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging study,” American Heart Journal, vol. 163, no. 3, pp. 500–507, 2012. View at Google Scholar
  16. G. Patti, G. Bárczi, D. Orlic et al., “Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI, (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study,” Journal of the American College of Cardiology, vol. 58, no. 15, pp. 1592–1599, 2011. View at Google Scholar
  17. F. Mangiacapra, O. Muller, A. Ntalianis et al., “Comparison of 600 versus 300-mg clopidogrel loading dose in patients with St-segment elevation myocardial infarction undergoing primary coronary angioplasty,” American Journal of Cardiology, vol. 106, no. 9, pp. 1208–1211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Siller-Matula, K. Huber, G. Christ et al., “Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis,” Heart, vol. 97, no. 2, pp. 98–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Montalescot, L. Bolognese, D. Dudek et al., “A Comparison of prasugrel at the time of percutaneous Coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study,” American Heart Journal, vol. 161, no. 4, pp. 650.e1–656.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Wallentin, R. C. Becker, A. Budaj et al., “Ticagrelor versus clopidogrel in patients with acute coronary syndromes,” The New England Journal of Medicine, vol. 361, no. 11, pp. 1045–1057, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Biondi-Zoccai, M. Lotrionte, P. Agostoni et al., “Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes,” International Journal of Cardiology, vol. 150, no. 3, pp. 325–331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. E. M. Antman, D. T. Anbe, P. W. Armstrong et al., “ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction),” Circulation, vol. 110, no. 5, pp. 588–636, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. E. M. Antman, M. Hand, P. W. Armstrong et al., “2007 focused update of the ACC/AHA, 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” Journal of the American College of Cardiology, vol. 51, no. 2, pp. 210–247, 2008. View at Google Scholar
  24. F. G. Kushner, M. Hand, S. C. Smith et al., “2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update),” Journal of the American College of Cardiology, vol. 54, no. 23, pp. 2205–2241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Anderson, C. D. Adams, E. M. Antman et al., “ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction),” Journal of the American College of Cardiology, vol. 50, no. 7, pp. e1–e157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. S. Wright, J. L. Anderson, C. D. Adams et al., “2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular,” Journal of the American College of Cardiology, vol. 57, no. 19, pp. 1920–1959, 2011. View at Google Scholar · View at Scopus
  27. H. Jneid, J. L. Anderson, R. S. Wright et al., “2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update),” Journal of the American College of Cardiology, vol. 60, no. 7, pp. 645–681, 2012. View at Google Scholar
  28. C. W. Hamm, J. P. Bassand, S. Agewall et al., “ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC),” European Heart Journal, vol. 32, no. 23, pp. 2999–3054, 2011. View at Google Scholar
  29. P. G. Steg, S. K. James, D. Atar et al., “ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC),” European Heart Journal, vol. 33, no. 20, pp. 2569–2619, 2012. View at Google Scholar